アルツハイマー病の認知スペクトルにおける神経精神症状の軌跡:認知および機能的低下による共同確率
Feng Jie Li1, Li Jie Guo1, Qi Gao1
1Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing 100069, China; Beijing Key Laboratory of Environment and Aging, Capital Medical University, Beijing, China.
Psychiatry research
|August 24, 2025
まとめ
神経精神症状 (NPS) は,アルツハイマー病 (AD) の患者で異なる進行をします. 重度の機能低下と急速な認知障害は,特に軽度の認知障害 (MCI) 段階での持続的なNPSと関連しています.
科学分野:
- 神経科学
- ゲロントロジー
- 精神科
背景:
- アルツハイマー病 (AD) は,神経精神症状 (NPS) の異質な発達と認知/機能的低下によって特徴付けられています.
- NPSの軌道を理解し,認知および機能的状態との関係を理解することは,ADの進行を管理するために不可欠です.
研究 の 目的:
- アルツハイマー病の異なる認知スペクトルにおける NPS 負荷の軌道を比較する.
- 認知機能の低下を伴う NPS の共同確率を決定する.
主な方法:
- アルツハイマー病ニューロ画像イニシアティブ (ADNI) のコホートから得られたデータを使用した.
- 認知障害 (CI),軽度の認知障害 (MCI),ADの集団におけるNPSの軌道を特定するために,グループベースの軌道のモデルを使用した.
- NPSに対する共同確率と影響を評価するために,二重軌道と線形混合効果モデルを適用した.
主要な成果:
- NPSの3つの経路が特定されました: ほぼ無症状で安定した,中程度の緩やかな上昇,および重度の持続的な悪化です.
- 性別,年齢,APOEε4状態,肥満によって影響されたCI,MCI,AD段階におけるNPSの重度および進行の変動が見つかりました.
- 急速な認知機能の低下は,中程度の慢上昇および重度の持続性のあるNPS,および重度の機能的低下は,中程度の慢上昇のNPSと関連しています.
結論:
- 軽度の認知障害 (MCI) とADの患者は,より重度のNPSとより速い進行を示します.
- 急速な認知障害と重度の機能低下は,重度の持続的なNPSを発症する可能性を高めます.
- 特にMCIの段階において,ADの相互に関連した症状の統合的管理の必要性を強調する.
さらに関連する動画
関連する概念動画
01:26Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
01:22Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
01:30Dementia
165
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
165
01:30Negative and Cognitive Symptoms of Schizophrenia
123
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
123
01:15Parkinson's Disease: Overview
703
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
703
01:30Cognitive Development During Adulthood
267
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
267